Rankings
▼
Calendar
APGE FY 2022 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
APGE
Apogee Therapeutics, Inc.
$4B
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$31M
Net Income
-$40M
EPS (Diluted)
$-0.79
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$16M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$152M
Total Liabilities
$10M
Stockholders' Equity
$142M
Cash & Equivalents
$152M
← Q1 2022
All Quarters